Literature DB >> 19153766

The CCTTT pentanucleotide microsatellite in iNOS promoter influences the clinical outcome in P. falciparum infection.

G Dhangadamajhi1, B N Mohapatra, S K Kar, M R Ranjit.   

Abstract

To assess the hypothesis that nitric oxide (NO) is critical in the pathogenesis of cerebral malaria, we analyzed those single nucleotide polymorphisms (SNPs) and microsatellite (MS) of the promoter region of inducible nitric oxide synthase (iNOS) gene which are known to enhance the NO production in vivo. A total of 428 (204 severe, 224 mild) adult patients living in the eastern part of India were analyzed. The single nucleotide substitutions -954G-->C was found to be very rare, and -1173C-->T was absent in this population. But interestingly, longer forms of MS were found to be significantly associated with severe malaria (OR = 2.89, 95% CI = 1.955-4.295, P < 0.0001), and the linear regression analysis revealed that the risk of severe malaria significantly increases as the summed repeat number in an individual increase (OR = 1.16, P = 0.0013). Further, the median plasma level of nitrate/nitrite (NOx) was observed to be high in mild patients compared to severe patients, and the level of parasitemia was significantly low among mild patients than severe ones. These findings suggest that the CCTTT repeats in iNOS may play a key role in the pathogenesis of severe malaria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153766     DOI: 10.1007/s00436-009-1329-9

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  29 in total

1.  Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S.

Authors:  A Agarwal; A Guindo; Y Cissoko; J G Taylor; D Coulibaly; A Koné; K Kayentao; A Djimde; C V Plowe; O Doumbo; T E Wellems; D Diallo
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

2.  Genes, nitric oxide and malaria in African children.

Authors:  Ian A Clark; Kirk A Rockett; David Burgner
Journal:  Trends Parasitol       Date:  2003-08

Review 3.  Cerebral malaria.

Authors:  G Turner
Journal:  Brain Pathol       Date:  1997-01       Impact factor: 6.508

4.  A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria.

Authors:  J C Knight; I Udalova; A V Hill; B M Greenwood; N Peshu; K Marsh; D Kwiatkowski
Journal:  Nat Genet       Date:  1999-06       Impact factor: 38.330

5.  Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow.

Authors:  Supattra Serirom; Wahaju H Raharjo; Kesinee Chotivanich; Sornchai Loareesuwan; Paul Kubes; May Ho
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

6.  High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria.

Authors:  C B Chiwakata; C J Hemmer; M Dietrich
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

Review 7.  Malaria in 2002.

Authors:  Brian Greenwood; Theonest Mutabingwa
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

Review 8.  The pathogenic basis of malaria.

Authors:  Louis H Miller; Dror I Baruch; Kevin Marsh; Ogobara K Doumbo
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

9.  Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene.

Authors:  N A Chartrain; D A Geller; P P Koty; N F Sitrin; A K Nussler; E P Hoffman; T R Billiar; N I Hutchinson; J S Mudgett
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

10.  Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria.

Authors:  Christian R Engwerda; Tracey L Mynott; Sanjeet Sawhney; J Brian De Souza; Quentin D Bickle; Paul M Kaye
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

View more
  6 in total

1.  Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale.

Authors:  Michael Hawkes; Robert Opika Opoka; Sophie Namasopo; Christopher Miller; Andrea L Conroy; Lena Serghides; Hani Kim; Nisha Thampi; W Conrad Liles; Chandy C John; Kevin C Kain
Journal:  Med Hypotheses       Date:  2011-07-13       Impact factor: 1.538

2.  Polymorphisms in host genes encoding NOSII, C-reactive protein, and adhesion molecules thrombospondin and E-selectin are risk factors for Plasmodium falciparum malaria in India.

Authors:  K Kanchan; S S Pati; S Mohanty; S K Mishra; S K Sharma; S Awasthi; V Venkatesh; S Habib
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-21       Impact factor: 3.267

3.  NOS2 variants reveal a dual genetic control of nitric oxide levels, susceptibility to Plasmodium infection, and cerebral malaria.

Authors:  Maria de Jesus Trovoada; Madalena Martins; Riadh Ben Mansour; Maria do Rosário Sambo; Ana B Fernandes; Lígia Antunes Gonçalves; Artur Borja; Roni Moya; Paulo Almeida; João Costa; Isabel Marques; M Paula Macedo; António Coutinho; David L Narum; Carlos Penha-Gonçalves
Journal:  Infect Immun       Date:  2013-12-30       Impact factor: 3.441

4.  Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial.

Authors:  Michael Hawkes; Robert O Opoka; Sophie Namasopo; Christopher Miller; Kevin E Thorpe; James V Lavery; Andrea L Conroy; W Conrad Liles; Chandy C John; Kevin C Kain
Journal:  Trials       Date:  2011-07-13       Impact factor: 2.279

5.  Polymorphisms in the RNASE3 gene are associated with susceptibility to cerebral malaria in Ghanaian children.

Authors:  Bright Adu; Daniel Dodoo; Selorme Adukpo; Ben A Gyan; Paula L Hedley; Bamenla Goka; George O Adjei; Severin O Larsen; Michael Christiansen; Michael Theisen
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

6.  Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study.

Authors:  Tobias O Apinjoh; Judith K Anchang-Kimbi; Clarisse Njua-Yafi; André N Ngwai; Regina N Mugri; Taane G Clark; Kirk A Rockett; Dominic P Kwiatkowski; Eric A Achidi
Journal:  Malar J       Date:  2014-06-16       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.